Luminus Management’s Lucid Diagnostics LUCD Stock Holding History
Bought
Maintained
Sold
Other funds holding LUCD
VCM
MCM
TSC
PCM
Luminus Management's LUCD Position: Q1 2026 in Review
Luminus Management sold out of Lucid Diagnostics (LUCD) in Q1 2026, closing a stake of 370,969 shares — an estimated $404K sold.
Luminus Management first reported a position in LUCD in Q4 2021 and held it in 17 quarters. The position peaked at $6.76M in Q4 2021. 103 funds tracked by Wall St. Rank hold LUCD as of Q1 2026.
- Luminus Management reported no remaining Lucid Diagnostics position as of Q1 2026 after selling out during the quarter.
- Luminus Management sold 370,969 Lucid Diagnostics shares in Q1 2026, an estimated $404K.
- Luminus Management first reported a position in Lucid Diagnostics in Q4 2021 and held it in 17 quarters.
- Luminus Management's Lucid Diagnostics position peaked at $6.76M in Q4 2021.
- 103 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q1 2026.
Based on Luminus Management's 13F filing for Q1 2026, filed 15 May 2026.